TFF Pharmaceuticals, Inc.
Total Trades
22
Buys
19
Sells
2
Largest Trade
$1M+
Insiders
10
Institutional Funds
1
Inst. Value
N/A
Activist Filings
13
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| CARLSON CAPITAL L P | 10% Owner | SELL | $50K–$100K | 216K | $0.44 | Aug 17, 2023 |
| Weisman Harlan F | President and CEO | BUY | $100K–$500K | 600K | $0.25 | Aug 15, 2023 |
| ROCAMBOLI STEPHEN | Director | BUY | $1K–$15K | 20K | $0.25 | Aug 15, 2023 |
| Roberts Brandi | Director | BUY | $1K–$15K | 20K | $0.25 | Aug 15, 2023 |
| COLEMAN KIRK ALLEN | CFO | BUY | $1K–$15K | 20K | $0.25 | Aug 15, 2023 |
| MILLS ROBERT S | Director | BUY | $1K–$15K | 40K | $0.25 | Aug 15, 2023 |
| Mikhak Zamaneh | Chief Medical Offi… | BUY | $15K–$50K | 120K | $0.25 | Aug 15, 2023 |
| ROCAMBOLI STEPHEN | Director | BUY | $1K–$15K | 13K | $0.80 | Mar 13, 2023 |
| COLEMAN KIRK ALLEN | CFO | BUY | $1K–$15K | 12K | $0.79 | Mar 13, 2023 |
| Weisman Harlan F | President and CEO | BUY | $100K–$500K | 150K | $0.88 | Mar 13, 2023 |
| Mikhak Zamaneh | Chief Medical Offi… | BUY | $1K–$15K | 15K | $0.82 | Mar 13, 2023 |
| Weisman Harlan F | President and CEO | BUY | $50K–$100K | 50K | $1.06 | Dec 19, 2022 |
| Fletcher Aaron G.L. | Director | BUY | $15K–$50K | 43K | $1.15 | Nov 23, 2022 |
| THURMAN RANDY H | Director | SELL | $100K–$500K | 40K | $4.29 | Sep 30, 2022 |
| THURMAN RANDY H | Director | EXERCISE | $100K–$500K | 40K | $2.50 | Sep 30, 2022 |
| Weisman Harlan F | Director | BUY | $15K–$50K | 7K | $5.37 | May 20, 2022 |
| Fletcher Aaron G.L. | Director | BUY | $500K+ | 110K | $4.91 | May 18, 2022 |
| Weisman Harlan F | Director | BUY | $1K–$15K | 3K | $4.74 | May 18, 2022 |
| COLEMAN KIRK ALLEN | CFO | BUY | $1K–$15K | 2K | $4.51 | May 18, 2022 |
| Mattes Glenn R. | President and CEO | BUY | $50K–$100K | 16K | $4.78 | May 18, 2022 |
| ROCAMBOLI STEPHEN | Director | BUY | $1K–$15K | 3K | $4.54 | May 18, 2022 |
| Fletcher Aaron G.L. | Director | BUY | $1M+ | 542K | $6.47 | Apr 4, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 1 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| DRW Securities, LLC | 40K | N/A | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Double Black Diamond Offshore Ltd.
SC 13G/A · Nov 19, 2024
3.5%
124K shares
SC 13G · Nov 14, 2024
10.0%
359K shares
SC 13G · May 8, 2024
5.0%
156K shares
Double Black Diamond Offshore Ltd.
SC 13G/A · May 8, 2024
9.1%
218K shares
SC 13G/A · Feb 14, 2024
0.1%
12K shares
Lung Therapeutics, Inc. 46-1383209
SC 13G/A · Feb 14, 2023
2.1%
773K shares
SC 13G/A · Feb 13, 2023
8.4%
3.1M shares
Double Black Diamond Offshore Ltd.
SC 13G/A · Feb 9, 2023
5.1%
1.8M shares
Double Black Diamond Offshore Ltd.
SC 13G · Nov 28, 2022
6.2%
2.2M shares
SC 13G · Nov 23, 2022
8.8%
3.1M shares
SC 13G/A · Feb 14, 2022
0.0%
0 shares
Lung Therapeutics, Inc. 46-138209
SC 13G/A · Feb 14, 2022
8.8%
2.2M shares
Nantahala Capital Management, LLC
SC 13G/A · Feb 14, 2022
0.0%
0 shares